In ETP-ALL, mutations in DNMT3A, ETV6, FLT3, GATA3, IDH1, IDH2, JAK3, NRAS/KRAS, and RUNX1 genes have been seen with greater frequency in comparison to non-ETP-ALL cases [17]. This evidence concerns the gene KRAS and acute lymphoblastic leukemia.